Bobbie Adams
Nurse Practitioner · Lexington, KYNPI 1396958245
Payments from drug & device makers
Across 169 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$1K
- Catalyst Pharmaceuticals, Inc.$593
- SK Life Science, Inc.$456
- Avanir Pharmaceuticals, Inc.$272
- Teva Pharmaceuticals USA, Inc.$247
- Biohaven Pharmaceuticals, Inc.$166
- plus $1K from 27 others
What the payments were for
- Food & beverage$4,35999%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 9 | $1,197 |
| Catalyst Pharmaceuticals, Inc. | 25 | $593 |
| SK Life Science, Inc. | 20 | $456 |
| Avanir Pharmaceuticals, Inc. | 16 | $272 |
| Teva Pharmaceuticals USA, Inc. | 13 | $247 |
| Biohaven Pharmaceuticals, Inc. | 7 | $166 |
| AbbVie | 10 | $159 |
| Livanova USA, Inc. | 5 | $117 |
| Jazz Pharmaceuticals Inc. | 5 | $116 |
| Eisai Inc. | 7 | $113 |
| Amgen | 5 | $85 |
| Grifols USA, LLC | 4 | $83 |
| Lundbeck LLC | 4 | $78 |
| Indivior Inc. | 3 | $69 |
| Lilly USA, LLC | 4 | $67 |
| Sumitomo Pharma America, Inc. | 4 | $67 |
| Almatica Pharma LLC | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| UCB, Inc. | 4 | $53 |
| Neurocrine Biosciences, Inc. | 2 | $36 |
| Orexo US, Inc. | 2 | $34 |
| MDD US Operations, LLC | 2 | $31 |
| Pfizer | 2 | $28 |
| Gilead | 1 | $26 |
| Braeburn Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$114
How this compares
$4,390 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 783 | $68,377 |
| UbrelvyUbrogepant | 51 | $62,114 |
| QuliptaAtogepant | 52 | $58,293 |
| AptiomEslicarbazepine Acetate | 32 | $39,498 |
| Emgality PenGalcanezumab-Gnlm | 24 | $21,307 |
| BotoxOnabotulinumtoxina | 14 | $17,920 |
| BriviactBrivaracetam | 12 | $17,832 |
| Trokendi XrTopiramate | 12 | $15,377 |
| Ajovy SyringeFremanezumab-Vfrm | 12 | $12,982 |
| Aimovig AutoinjectorErenumab-Aooe | 16 | $11,629 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $8,803 |
| XareltoRivaroxaban | 12 | $6,429 |
| RytaryCarbidopa/Levodopa | 11 | $4,046 |
| Buprenorphine Hcl | 55 | $1,101 |
| Levetiracetam | 49 | $736 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta, Botox | $159 | $138,326117 claims |
| UCB, Inc.Briviact | $53 | $17,83212 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $16 | $15,37712 claims |
| Indivior Inc.Suboxone | $69 | $8,80325 claims |
| Johnson & JohnsonXarelto | $23 | $6,42912 claims |
| Amneal Pharmaceuticals LLCRytary | $15 | $4,04611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Lexington
- Rachael BradfordLexington$447K
- Juawanna SchullerLexington$26K
- Jessica SchorckLexington$26K
- Amelia HendricksonLexington$22K
- Megan CollettLexington$13K
- Amy NydamLexington$11K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.